Analytical Data
-
基因名
LPGAT1
- Application
-
别名
LPGAT1; FAM34A; KIAA0205; Acyl-CoA:lysophosphatidylglycerol acyltransferase 1; Acyl-CoA:monoacylglycerol acyltransferase LPGAT1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q92604
-
表达区间
1-370aa
-
氨基酸序列
MAITLEEAPWLGWLLVKALMRFAFMVVNNLVAIPSYICYVIILQPLRVLDSKRFWYIEGIMYKWLLGMVASWGWYAGYTVMEWGEDIKAVSKDEAVMLVNHQATGDVCTLMMCLQDKGLVVAQMMWLMDHIFKYTNFGIVSLVHGDFFIRQGRSYRDQQLLLLKKHLENNYRSRDRKWIVLFPEGGFLRKRRETSQAFAKKNNLPFLTNVTLPRSGATKIILNALVAQQKNGSPAGGDAKELDSKSKGLQWIIDTTIAYPKAEPIDIQTWILGYRKPTVTHVHYRIFPIKDVPLETDDLTTWLYQRFVEKEDLLSHFYETGAFPPSKGHKEAVSREMTLSNLWIFLIQSFAFLSGYMWYNIIQYFYHCLF
-
分子量
69.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human NDUFS5 Protein，His
Cat：PA1000-2124
Recombinant Human Cmklr1 Protein，His
Cat：PA2000-4853
Protein Description
LPGAT1 (Lysophosphatidylglycerol acyltransferase 1) is an enzyme that plays a critical role in the biosynthesis of glycerolipids, which are essential components of cell membranes. This enzyme catalyzes the acylation of lysophosphatidylglycerol to form phosphatidylglycerol, a key lipid involved in various cellular functions, including membrane dynamics, signaling pathways, and energy metabolism. Research into LPGAT1 has gained momentum due to its potential implications in various biological processes and diseases, such as cardiovascular disorders, metabolic syndromes, and neurological conditions. The recombinant expression of LPGAT1 in heterologous systems provides a valuable tool for studying its biochemical characteristics and functional significance. Understanding the enzyme's structure, substrate specificity, and regulatory mechanisms can shed light on its role in lipid metabolism and its contribution to disease pathology. Furthermore, recombinant LPGAT1 can serve as a platform for developing therapeutic strategies aimed at modulating lipid profiles in disease states, highlighting the importance of ongoing research in this area. Overall, the exploration of LPGAT1 not only advances our knowledge of lipid biochemistry but also opens avenues for innovative treatments targeting related metabolic and degenerative diseases.
